Coya Therapeutics (COYA) Institutional Ownership $6.18 -0.35 (-5.36%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$6.28 +0.10 (+1.68%) As of 04/25/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Coya Therapeutics (NASDAQ:COYA)CurrentInstitutional OwnershipPercentage39.75%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$13.82MNumber ofInstitutional Sellers(last 12 months)0 Get COYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COYA Institutional Buying and Selling by Quarter Coya Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025DME Capital Management LP1,646,440$9.43M0.5%+29.2%9.853% 2/14/2025Jane Street Group LLC12,961$74K0.0%N/A0.078% 2/14/2025Northern Trust Corp28,549$164K0.0%+12.2%0.171% 2/14/2025Tower Research Capital LLC TRC 5,252$30K0.0%+1,005.7%0.031% 2/13/2025XTX Topco Ltd10,299$59K0.0%N/A0.062% 2/12/2025Geode Capital Management LLC150,576$863K0.0%+5.8%0.901% 2/12/2025AIGH Capital Management LLC1,201,152$6.88M2.2%+85.0%7.188% 2/7/2025CM Management LLC160,000$917K0.8%+11.1%0.958% 1/28/2025Newbridge Financial Services Group Inc.70,000$401K0.1%N/A0.419% 11/16/2024Geode Capital Management LLC142,309$918K0.0%+3.3%0.852% 10/24/2024 GHP Investment Advisors Inc.26,171$169K0.0%N/A0.179% 8/9/2024Renaissance Technologies LLC16,700$101K0.0%N/A0.114% 8/1/2024Gilbert & Cook Inc.10,000$61K0.0%N/A0.068% 5/10/2024Vanguard Group Inc.847,490$8.41M0.0%+772.3%5.804% 2/15/2024Greenlight Capital Inc.1,274,026$9.44M0.5%+172.2%12.702% 2/12/2024AIGH Capital Management LLC1,031,977$7.38M2.9%+92.6%10.289% 2/9/2024Worth Venture Partners LLC92,667$687K0.4%-30.8%0.924% 11/15/2023Worth Venture Partners LLC134,006$519K0.3%-8.5%1.336% 11/13/2023AIGH Capital Management LLC535,794$2.06M1.0%-8.7%5.342% 11/7/2023CM Management LLC100,000$384K0.4%+66.7%1.005% 8/14/2023 Mirador Capital Partners LP15,361$63K0.0%N/A0.154% 8/4/2023CM Management LLC60,000$244K0.2%N/A0.603% 2/16/2023AIGH Capital Management LLC560,000$2.65M0.9%N/A5.785% (Data available from 1/1/2016 forward) COYA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COYA shares? During the previous two years, 16 institutional investors and hedge funds held shares of Coya Therapeutics. The most heavily invested institutionals were Greenlight Capital Inc. ($9.44M), DME Capital Management LP ($9.43M), Vanguard Group Inc. ($8.41M), AIGH Capital Management LLC ($6.88M), CM Management LLC ($917K), Geode Capital Management LLC ($863K), and Worth Venture Partners LLC ($687K).Learn more on COYA's institutional investors. What percentage of Coya Therapeutics stock is owned by institutional investors? 39.75% of Coya Therapeutics stock is owned by institutional investors. Learn more on COYA's institutional investor holdings. Which institutional investors have been buying Coya Therapeutics stock? Of the 15 institutional investors that purchased Coya Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($1.05M), Greenlight Capital Inc. ($805.96K), Vanguard Group Inc. ($750.34K), DME Capital Management LP ($372.41K), CM Management LLC ($115.94K), Newbridge Financial Services Group Inc. ($70K), and GHP Investment Advisors Inc. ($26.17K). How much institutional buying is happening at Coya Therapeutics? Institutional investors have bought a total of 3,274,680 shares in the last 24 months. This purchase volume represents approximately $23.93M in transactions. Which Coya Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Coya Therapeutics stock in the last 24 months: Worth Venture Partners LLC ($53.83K), and AIGH Capital Management LLC ($51.08K). How much institutional selling is happening at Coya Therapeutics? Institutional investors have sold a total of 104,904 shares in the last 24 months. This volume of shares sold represents approximately $550.41K in transactions. Related Companies Revance Therapeutics Institutional Ownership Rapport Therapeutics Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Kamada Institutional Ownership Zevra Therapeutics Institutional Ownership Mereo BioPharma Group Institutional Ownership Altimmune Institutional Ownership Sana Biotechnology Institutional Ownership SNDL Institutional Ownership Erasca Institutional Ownership This page (NASDAQ:COYA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
